See the Full Picture.

Published 2 years ago • loading... • Updated 2 years ago

Cell and Gene Therapy Manufacturing Costs Limiting Access

Summary by Ground News

High production costs are limiting patient access to cell and gene therapies. Researchers say optimizing manufacturing methods and increasing capacity industry-wide would help. Analysis by the Institute for Clinical and Economic Review (ICER) suggests the average cost of a gene therapy is between $1 million and $2 million per dose.

1 Articles

1 Articles

All

Left

Center

Right

GEN - Genetic Engineering and Biotechnology News…

Cell and Gene Therapy Manufacturing Costs Limiting Access

The cell and gene therapy industry needs support to increase production capacity.

2 years ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated2 years agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GEN - Genetic Engineering and Biotechnology News… broke the news in 2 years ago on Tuesday, February 21, 2023.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics